These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19438449)

  • 1. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
    Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Mao HR
    Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary invasive carcinoma associated with penoscrotal extramammary Paget's disease: a clinicopathological analysis of 56 cases.
    Dai B; Kong YY; Chang K; Qu YY; Ye DW; Zhang SL; Zhang HL
    BJU Int; 2015 Jan; 115(1):153-60. PubMed ID: 24731175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary invasive extramammary Paget disease on penoscrotum: a clinicopathological analysis of 41 cases.
    Shu B; Shen XX; Chen P; Fang XZ; Guo YL; Kong YY
    Hum Pathol; 2016 Jan; 47(1):70-7. PubMed ID: 26508372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frozen section-guided wide local excision in the treatment of penoscrotal extramammary Paget's disease.
    Zhu Y; Ye DW; Chen ZW; Zhang SL; Qin XJ
    BJU Int; 2007 Dec; 100(6):1282-7. PubMed ID: 17850363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
    Hirai I; Funakoshi T
    J Dermatol; 2017 Oct; 44(10):1148-1151. PubMed ID: 28406527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphovascular and marginal invasion as useful prognostic indicators and the role of c-erbB-2 in patients with male extramammary Paget's disease: a study of 31 patients.
    Choi YD; Cho NH; Park YS; Cho SH; Lee G; Park K
    J Urol; 2005 Aug; 174(2):561-5. PubMed ID: 16006892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Observations on signet cell invasion and metastasis in extra-mammary Paget's disease].
    Xu H; Li N; Li W
    Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):294-5. PubMed ID: 9388876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.
    Liu H; Urabe K; Uchi H; Takeuchi S; Nakahara T; Dainichi T; Tu Y; Furue M; Moroi Y
    J Cutan Pathol; 2007 Jan; 34(1):33-8. PubMed ID: 17214852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease.
    Kariya K; Tsuji T; Schwartz RA
    Dermatol Surg; 2004 Feb; 30(2 Pt 2):341-4. PubMed ID: 14871231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.
    Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M
    Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extramammary Paget's disease: treatment, prognostic factors and outcome in 76 patients.
    Hatta N; Yamada M; Hirano T; Fujimoto A; Morita R
    Br J Dermatol; 2008 Feb; 158(2):313-8. PubMed ID: 18028492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy.
    Takahagi S; Noda H; Kamegashira A; Madokoro N; Hori I; Shindo H; Mihara S; Hide M
    J Dermatol; 2009 Aug; 36(8):457-61. PubMed ID: 19691751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic indicators in 35 patients with extramammary Paget's disease.
    Ito Y; Igawa S; Ohishi Y; Uehara J; Yamamoto AI; Iizuka H
    Dermatol Surg; 2012 Dec; 38(12):1938-44. PubMed ID: 22989161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
    Aoyagi S; Akiyama M; Shimizu H
    J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics of extramammary Paget's disease of the scrotum associated with sweat gland adenocarcinoma-a clinical retrospective study.
    Yan D; Dai H; Jin M; Zhao Y
    J Chin Med Assoc; 2011 Apr; 74(4):179-82. PubMed ID: 21463849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC5AC expression correlates with invasiveness and progression of extramammary Paget's disease.
    Hata H; Abe R; Hoshina D; Saito N; Homma E; Aoyagi S; Shimizu H
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):727-32. PubMed ID: 23581859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes in a large cohort of patients with invasive Extramammary Paget's disease.
    Karam A; Dorigo O
    Gynecol Oncol; 2012 May; 125(2):346-51. PubMed ID: 22293043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of docetaxel as first-line chemotherapy for metastatic extramammary Paget's disease.
    Yoshino K; Fujisawa Y; Kiyohara Y; Kadono T; Murata Y; Uhara H; Hatta N; Uchi H; Matsushita S; Takenouchi T; Hayashi T; Ohara K
    J Dermatol; 2016 Jun; 43(6):633-7. PubMed ID: 26603144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain metastasis from extramammary Paget's disease of the scrotum.
    Kim IY; Yun SJ; Lee JS; Jung S; Jung TY; Moon KS; Jang WY
    J Clin Neurosci; 2014 Apr; 21(4):694-6. PubMed ID: 24210806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease.
    Cho Z; Konishi E; Kanemaru M; Isohisa T; Arita T; Kawai M; Tsutsumi M; Mizutani H; Takenaka H; Ozawa T; Tsuruta D; Katoh N; Asai J
    J Dermatol Sci; 2017 Jul; 87(1):29-35. PubMed ID: 28381343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.